Tue, February 13, 2024

Joseph Schwartz Downgraded (ANTX) to Hold and Decreased Target to $7 on, Feb 13th, 2024

Joseph Schwartz of Leerink Partners, Downgraded "AN2 Therapeutics, Inc." (ANTX) to Hold and Decreased Target from $23 to $7 on, Feb 13th, 2024.

Joseph has made no other calls on ANTX in the last 4 months.



There are 3 other peers that have a rating on ANTX. Out of the 3 peers that are also analyzing ANTX, all agree with Joseph's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Jeff Jones of "Oppenheimer" Downgraded from Buy to Hold on, Monday, February 12th, 2024
  • Liisa Bayko of "Evercore ISI Group" Downgraded from Buy to Hold and Decreased Target to $7 on, Monday, February 12th, 2024
  • Roy Buchanan of "JMP Securities" Downgraded from Buy to Hold on, Monday, February 12th, 2024